Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange

Contributed by: PR Newswire

Tags

QimingVenturePartners

More Like This

China's AGI Pioneer and Leader Z.ai Listed on Hong Kong Stock Exchange

PR Newswire associated0

Ribo Life Science (06938.HK) Successfully Lists on the Main Board of the Hong Kong Stock Exchange

Qiming Venture Partners' Portfolio Company Yunji Technology Successfully Lists on the Hong Kong Stock Exchange

PR Newswire associated0

Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology

Domestic GPU Leader Biren Technology Listed on Hong Kong Stock Exchange

Qiming Venture Partners Promotes Alex Zhou to Managing Partner

Business Wire associated0

Biocytogen Completes STAR Market IPO, Becoming the First “H+A” Global Drug Innovator

Kexing Biopharm Enters Strategic Partnership with IQVIA to Accelerate Global Expansion